Brazilian Journal of Nephrology (Jul 2023)

mTOR inhibitors are the first-choice therapy for renal angiomyolipomas secondary to tuberous sclerosis

  • Aline Grosskopf Monich,
  • Mariana Faucz Munhoz da Cunha,
  • Fellype Carvalho Barreto

DOI
https://doi.org/10.1590/2175-8239-jbn-2023-0077en

Abstract

Read online Read online

No abstracts available.